Cursor is nearing a funding round of at least $2 billion, with returning investors Thrive and Andreessen Horowitz expected to lead the financing at a $50 billion valuation. The deal terms are not final and may still change.
Inertia Enterprises burst onto the scene in February with a $450 million Series A, making it one of the best capitalized startups in the industry, aiming to bring laser-based fusion reactors to market.
Helical's thesis is that bio foundation models, AI systems trained on vast genomic, transcriptomic, and proteomic datasets, have already crossed a quality threshold that makes computational hypothesis-testing meaningful in pharma research.
Modern scientific societies are increasingly vulnerable due to their dependence on membership fees and journal subscriptions, which are being challenged by the rise of virtual networking and open-access publishing.
Starting this year, organizations based in or controlled by China cannot apply for grants to fund projects involving artificial intelligence, telecommunications such as 5G, health, semiconductors, biotechnology or quantum technologies. China's Seven Sons of National Defence, a group of universities affiliated with the government's ministry of industry and information technology, are also barred from all funding. However, Chinese organizations can still apply for or participate in select research projects related to climate, biodiversity, food and agriculture.
Scientists are increasingly turning to artificial-intelligence systems for help drafting the grant proposals that fund their careers, but preliminary data indicate that these tools might be pulling the focus of research towards safe, less-innovative ideas. These data provide evidence that AI-assisted proposals submitted to the US National Institutes of Health (NIH) are consistently less distinct from previous research than ones written without the use of AI - and are also slightly more likely to be funded.
But he'd been considering an idea for new technology-an autonomous, wind-powered cargo ship. Then, while on paternity leave in 2024, he discovered a free program that helps scientists and engineers launch businesses for the first time. Weeks after finishing the program, called 5050, Cymbalist had launched a startup called Clippership. The company's first ship is being built in the Netherlands this year. Without the accelerator, he says, the company likely wouldn't exist.
As global competition in space accelerates, New York is mobilizing its premier research institutions through NYCST to address workforce shortages, close capability gaps and mature the critical technologies our nation needs. For decades, our state has been a home to innovative aerospace companies. Through NYCST, we are now aligning that heritage with our top-tier research institutions to ensure that industry can develop and scale up breakthrough technologies right here in New York.
Because startups typically don't have a track record of success to attract potential clients, they can offer a trial of their platform for free or at a lower cost to showcase what their platform can do and how reliable it is. The enterprise - a potential client - can test the newest technologies without the worry of committing to a complete and often costly rollout.
The fewer solicitations you have, the less time grant applicants have to figure out which of our pigeonholes they fit into. In the past, a solicitation might have been for an individual program, which means it's attached to an individual program officer and a specific dollar amount. Now, instead of going to one program officer's area, the NSF will use technology to better route applications to wherever within the agency they can best be reviewed.
The boss of UK Research and Innovation (UKRI), the public body which spends 8bn of taxpayer money each year on research and innovation in the UK, has warned the organisation faces "hard decisions" on funding future projects. In an open letter, Ian Chapman said the government had told it to "focus and do fewer things better", which "will result in negative outcomes for some".
